NM_001172303.3:c.660+12A>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001172303.3(MASTL):​c.660+12A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.622 in 1,577,492 control chromosomes in the GnomAD database, including 309,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27731 hom., cov: 30)
Exomes 𝑓: 0.62 ( 281610 hom. )

Consequence

MASTL
NM_001172303.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.21

Publications

18 publications found
Variant links:
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]
MASTL Gene-Disease associations (from GenCC):
  • autosomal thrombocytopenia with normal platelets
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-27165182-A-T is Benign according to our data. Variant chr10-27165182-A-T is described in ClinVar as Benign. ClinVar VariationId is 262126.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.643 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MASTLNM_001172303.3 linkc.660+12A>T intron_variant Intron 5 of 11 ENST00000375940.9 NP_001165774.1 Q96GX5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MASTLENST00000375940.9 linkc.660+12A>T intron_variant Intron 5 of 11 1 NM_001172303.3 ENSP00000365107.5 Q96GX5-1
MASTLENST00000375946.8 linkc.660+12A>T intron_variant Intron 5 of 11 1 ENSP00000365113.4 Q96GX5-3
MASTLENST00000342386.10 linkc.660+12A>T intron_variant Intron 5 of 10 2 ENSP00000343446.5 Q96GX5-2

Frequencies

GnomAD3 genomes
AF:
0.601
AC:
91263
AN:
151778
Hom.:
27737
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.554
Gnomad AMI
AF:
0.622
Gnomad AMR
AF:
0.570
Gnomad ASJ
AF:
0.629
Gnomad EAS
AF:
0.426
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.662
Gnomad MID
AF:
0.585
Gnomad NFE
AF:
0.649
Gnomad OTH
AF:
0.593
GnomAD2 exomes
AF:
0.591
AC:
148154
AN:
250732
AF XY:
0.590
show subpopulations
Gnomad AFR exome
AF:
0.549
Gnomad AMR exome
AF:
0.536
Gnomad ASJ exome
AF:
0.617
Gnomad EAS exome
AF:
0.434
Gnomad FIN exome
AF:
0.663
Gnomad NFE exome
AF:
0.650
Gnomad OTH exome
AF:
0.617
GnomAD4 exome
AF:
0.625
AC:
890655
AN:
1425596
Hom.:
281610
Cov.:
26
AF XY:
0.621
AC XY:
442201
AN XY:
711538
show subpopulations
African (AFR)
AF:
0.554
AC:
18093
AN:
32664
American (AMR)
AF:
0.537
AC:
24000
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.619
AC:
16021
AN:
25900
East Asian (EAS)
AF:
0.398
AC:
15707
AN:
39468
South Asian (SAS)
AF:
0.492
AC:
42024
AN:
85450
European-Finnish (FIN)
AF:
0.661
AC:
35264
AN:
53350
Middle Eastern (MID)
AF:
0.579
AC:
3293
AN:
5690
European-Non Finnish (NFE)
AF:
0.649
AC:
700070
AN:
1079212
Other (OTH)
AF:
0.611
AC:
36183
AN:
59196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
16257
32514
48772
65029
81286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17984
35968
53952
71936
89920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.601
AC:
91267
AN:
151896
Hom.:
27731
Cov.:
30
AF XY:
0.600
AC XY:
44502
AN XY:
74210
show subpopulations
African (AFR)
AF:
0.553
AC:
22887
AN:
41410
American (AMR)
AF:
0.570
AC:
8703
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.629
AC:
2180
AN:
3466
East Asian (EAS)
AF:
0.425
AC:
2188
AN:
5148
South Asian (SAS)
AF:
0.479
AC:
2305
AN:
4814
European-Finnish (FIN)
AF:
0.662
AC:
6962
AN:
10518
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.649
AC:
44067
AN:
67946
Other (OTH)
AF:
0.585
AC:
1236
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1812
3624
5437
7249
9061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.627
Hom.:
5573
Bravo
AF:
0.593
Asia WGS
AF:
0.443
AC:
1542
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Thrombocytopenia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.0
DANN
Benign
0.67
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7068375; hg19: chr10-27454111; COSMIC: COSV60909955; COSMIC: COSV60909955; API